Point of Care Diagnostics

Table of Contents

• INTRODUCTION
  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • SCOPE AND FORMAT
  • CONTRIBUTIONS OF THE STUDY AND AUDIENCE
  • METHODOLOGY AND INFORMATION SOURCES
  • RELATED BCC WORK CREDENTIALS
  • BCC ONLINE SERVICES
  • DISCLAIMER
• EXECUTIVE SUMMARY
  • OVERVIEW
  • MAJOR FINDINGS
  • Summary Table: FORECAST OF THE U.S. POC MARKET BY APPLICATION, THROUGH 2010 ($ BILLIONS)
  • Summary Figure: FORECAST OF THE U.S. POC MARKET BY APPLICATION, 2005 AND 2010 ($ BILLIONS)
• POINT OF CARE TESTING
  • WHAT IS POINT OF CARE TESTING?
  • OVERVIEW OF POINT OF CARE (POC) MARKET
  • POC AS PART OF CLINICAL DIAGNOSTICS INDUSTRY STRUCTURE
    • MEDICAL BENEFITS DERIVED FROM IMMEDIATE DIAGNOSTIC TESTING
  • POC TESTING SITES
    • HOME USE/ SELF CARE
    • EMERGENCY ROOMS (ER)
    • CRITICAL CARE UNITS (CCU)
    • BEDSIDE TESTING
    • OPERATING ROOMS (OR)/ PROCEDURE ROOMS (PR)
    • PHYSICIANS OFFICES/ CLINICS/ TREATMENT CENTERS/OTHER NON-CRITICAL CARE SITES
  • Table 1 SELECTED KEY STATISTICS POC TESTING SITES
    • POC PRODUCT SEGMENTS
      • POC CLINICAL ASSAY CATEGORIES
        • Blood Gases and Electrolytes
        • Clinical Chemistry
          • Glucose Testing
        • Hematology and Hemostasis
        • Urinalysis
        • Immunoassay/Microbiology
    • COMMONLY PERFORMED POC TESTS
  • Table 2 SELECTED POC TESTS - CLIA WAIVED
    • SIGNIFICANCE OF CLIA
    • OTHER REGULATORY AGENCIES
      • FDA (FOOD AND DRUG ADMINISTRATION)
        • Good Manufacturing Practice (GMP)
  • Table 3 PERTINENT PARAMETERS OF GMP REGULATIONS AFFECTING IN VITRO DIAGNOSTICS
    • DRIVING FORCES OF THE POC MARKET
      • COST CONTAINMENT
      • TECHNOLOGICAL ADVANCEMENT
        • Availability - Ease of Use Devices
        • New Technologies
          • Biosensors
      • CHANGES IN INCIDENCE OF DISEASE
        • Diabetes
        • Asthma
        • Cardiovascular Disease
        • Pulmonary Disease
      • AGING POPULATION
  • Table 4 U.S. POPULATION PROJECTIONS OF THOSE AGED 55+, 2000 AND 2010 (MILLIONS)
  • Figure 1 U.S. POPULATION PROJECTIONS OF THOSE AGED 55+, 2000 AND 2010 (MILLIONS)
• THE POINT OF CARE (POC) MARKET
  • THE POINT OF CARE (POC) MARKET
  • Table 5 FORECAST FOR THE U.S. POC MARKET BY VOLUME AND VALUE, THROUGH 2010 (MILLIONS)
  • Figure 2 FORECAST VALUE FOR THE U.S. POC MARKET, 2005 AND 2010 ($ MILLIONS)
    • MARKET SHARE
  • Table 6 MARKET SHARE POC MARKET PARTICIPANTS (%)
  • Figure 3 MARKET SHARE POC MARKET PARTICIPANTS (%)
    • MARKET STRUCTURE
      • DISTRIBUTION
  • Figure 4 DISTRIBUTION CHANNELS: POC DIAGNOSTIC DEVICES
    • PROMOTION
    • STRATEGIC ALLIANCES AND MERGERS
    • MARKET COMPONENTS
      • GLUCOSE TESTING
        • Glucose Testing (Continued)
        • Market Size
  • Table 7 FORECAST FOR THE U.S. GLUCOSE METERS AND RELATED SUPPLIES MARKET, THROUGH 2010 (MILLIONS)
  • Figure 5 FORECAST FOR THE U.S. GLUCOSE METERS AND RELATED SUPPLIES MARKET, 2005 AND 2010 ($ MILLIONS)
    • Meters
      • Market Size Type 1 Diabetics
      • Market Size Type 2 Diabetes
  • Table 8 HOME USE GLUCOSE METER SALES BY TYPE OF DIABETES, THROUGH 2010 (MILLIONS)
  • Figure 6 HOME USE GLUCOSE METER SALES BY TYPE OF DIABETES, 2005 AND 2010 ($ MILLIONS)
    • Related Supplies (Test Strips, Lancets, Controls)
  • Table 9 FORECAST OF U.S. GLUCOSE METER RELATED SALES, THROUGH 2010 (MILLIONS)
    • Test Strips
    • Lancets
      • Automatic Lancing Devices
      • Laser Skin Perforators
    • Control (Calibration) Solutions
    • Market Dynamics
  • Table 10 RECENTLY APPROVED CLIA POC BLOOD GLUCOSE METERS,* 2005
  • Table 10 (CONTINUED)
    • Market Participants
  • Table 11 RELATIVE MARKET SHARE GLUCOSE METERS AND SUPPLIES, 2005 (%)
  • Figure 7 RELATIVE MARKET SHARE GLUCOSE METERS AND SUPPLIES, 2005 (%)
    • Bayer Health Care
  • Table 12 BAYER GLUCOSE METER PRICES
    • Ascensia Breeze Glucometer
    • Ascensia Contour Glucometer
    • Ascensia Elite Glucometer
    • Ascencia DEX 2 Diabetes Care System
    • Abbott Diabetes Care
      • FreeStyle Blood Glucose Monitoring System
      • FreeStyle Flash Glucose Monitoring System
      • FreeStyle CoZmonitor
      • Precision Xtra
      • i-STAT 1
  • Table 13 ABBOTT GLUCOSE METER PRICES
    • Johnson and Johnson
      • LifeScan - ONE TOUCH® ULTRA® METER
      • LifeScan ONETOUCH ULTRASMART METER
      • LifeScan ONE TOUCH INDUO
      • LifeScan OneTouch Basic Meter
      • LifeScan OneTouch SureStep Meter
      • LifeScan OneTouch Diabetes Management Software
  • Table 14 LIFESCAN (J&J) GLUCOSE METER PRICES
    • Roche Diagnostic Systems
    • ACCU-CHEK Advantage System
    • ACCU-CHEK Aviva System
    • ACCU-CHEK Active Meter
    • ACCU-CHEK Compact Meter
    • ACCU-CHEK Complete Meter
    • Accu-Chek Go System
    • Accu-Chek Inform System
    • ACCU-CHEK Voicemate System
    • ACCU-CHEK Multiclix Lancet Device
    • ACCU-CHEK Softclixiclix Lancet Device
  • Table 15 ROCHE GLUCOSE METER PRICES
    • Home Diagnostics Inc.
      • Sidekick Testing System
      • TrueTrack Smart System
      • TrackEASE Smart System
      • Prestige IQ Blood Glucose Monitor
  • Table 16 SELECTED LISTING OF RETAILERS SELLING HOME DIAGNOSTICS METERS UNDER THEIR NAME
  • Table 17 HOME DIAGNOSTICS GLUCOSE METER PRICES
    • Hypoguard USA
      • At Home Use Glucose Meters
        • Reli-On NewTek
        • Advance Micro-draw Blood Glucose Monitoring System
        • Advance Intuition Blood Glucose Monitoring System
        • QuickTek Blood Glucose System
      • Professional Use
        • Assure 3 Blood Glucose Monitoring System
        • Assure II Blood Glucose Monitoring System
        • Supreme II Blood Glucose Monitoring System
        • Haemolance and Hemolance Plus Safety Lancets
  • Table 18 HYPOGUARD USA GLUCOSE METER PRICES
  • Table 18 (CONTINUED)
    • Becton Dickinson & Co.
      • BD Logic
    • QuestStar
      • Focus
      • Data Management Systems
  • Table 19 SELECTED LISTING OF BLOOD GLUCOSE MONITORS CAPABLE OF INTERACTING WITH COMPUTER SOFTWARE
    • BLOOD GASES AND ELECTROLYTE TESTING
      • Blood Gas Parameters
      • Electrolytes
      • Connectivity
      • Market Size
  • Table 20 FORECAST OF THE U.S. BLOOD GAS/ELECTROLYTE TESTING MARKET, THROUGH 2010 (MILLIONS)
    • Market Share
  • Table 21 RELATIVE MARKET SHARE OF BLOOD GAS ANALYZER MANUFACTURERS (%)
  • Figure 8 RELATIVE MARKET SHARE BLOOD GAS ANALYZER MANUFACTURERS (%)
    • Blood Gas and Electrolyte POC Products
  • Table 22 CLIA APPROVED POC BLOOD GAS ANALYZERS
    • CLIA Quality Control (QC) Requirements for Blood Gas Analysis
    • Radiometer America, Inc.
      • ABL 77
      • NPT7
    • Nova Biomedical
      • Stat Profile pHOx Product Line
  • Table 23 NOVA BIOCHEMICAL POC STAT PROFILE PHOX SERIES BY AVAILABLE TESTS
    • Point-of-Care Manager (PDM)
    • Bayer Diagnostics
      • Rapidpoint 440/405
    • Abbott Diagnostics
      • i-STAT
    • Instrumentation Laboratory
      • GEM® Premier 3000
      • GEM OPL
    • Roche Diagnostics
      • OMNI S
    • Osmetech
      • OPTI CCA Blood Gas Analyzer
    • Technidyne Corporation (ITC)
      • IRMA TRUpoint
    • CARDIAC MARKERS
      • Market Size
  • Table 24 FORECAST FOR THE U.S. CARDIAC MARKER TESTING MARKET, THROUGH 2010
    • Market Participants and Market Shares
  • Table 25 CARDIAC MARKET TESTS BY COMPANY
  • Table 26 RELATIVE SHARE POC CARDIAC MARKER MANUFACTURERS (%)
    • Biosite Diagnostics
      • Triage Meter Plus
    • Dade Behring
      • Stratus CS Acute Care Diagnostic System
    • Abbott
      • ISTAT 1
    • Roche
      • Cardiac Reader System
    • Spectral Diagnostics Inc
      • Cardiac STATus
      • i-Lynx
    • Response Biomedical
      • RAMP System
    • RAPID TESTS
      • Market Size
  • Table 27 FORECAST FOR THE U.S. POC RAPID TEST MARKET, THROUGH 2010 (MILLIONS)
  • Table 27 (CONTINUED)
  • Figure 9 FORECAST FOR THE U.S. POC RAPID TEST MARKET, 2005 AND 2010 ($ MILLIONS)
    • Market Participants
    • Rapid Test Products
      • Professional Use Rapid Test Products
        • Strep A
        • Market Size and Participants
  • Table 28 FORECAST FOR THE U.S. STREP A RAPID TEST, THROUGH 2010 (MILLIONS)
  • Table 29 MARKET SHARE OF STREP A RAPID TEST MANUFACTURERS (%)
  • Table 30 SELECTED LISTING CLIA APPROVED STREP A RAPID TESTS
  • Table 30 (CONTINUED)
    • H. Pylori
      • Market Size and Participants
  • Table 31 FORECAST FOR THE U.S. H. PYLORI RAPID TESTS, -THROUGH 2010 (MILLIONS)
  • Table 32 RELATIVE MARKET SHARE OF H. PYLORI POC RAPID TEST MANUFACTURERS (%)
  • Table 33 SELECTED LIST CLIA APPROVED H. PYLORI RAPID TESTS
    • Respiratory Syncytial Virus (RSV)
      • Market Size and Participants
  • Table 34 FORECAST FOR THE U.S. RSV RAPID TESTS, THROUGH 2010 (MILLIONS)
  • Table 35 SELECTED LISTING CLIA APPROVED RSV TESTS
    • Influenza
      • Market Size and Participants
  • Table 36 FORECAST FOR THE U.S. INFLUENZA RAPID TESTS, THROUGH 2010 (MILLIONS)
  • Table 37 RELATIVE MARKET SHARE OF INFLUENZA POC RAPID TEST MANUFACTURERS (%)
  • Table 38 SELECTED LISTING CLIA APPROVED INFLUENZA RAPID TESTS
    • Infectious Mononucleosis
      • Market Size and Participants
  • Table 39 FORECAST FOR THE U.S. INFECTIOUS MONONUCLEOS RAPID TESTS, -THROUGH 2010 (MILLIONS)
  • Table 40 MARKET SHARE POC INFECTIOUS MONONUCLEOSIS RAPID TESTS (%)
  • Table 41 SELECTED INTEREST CLIA APPROVED INFECTIOUS MONONUCLEOSIS RAPID TESTS
    • Chlamydia/Trichomonas
      • Market Size and Participants
  • Table 42 FORECAST FOR THE U.S. CHLAMYDIA/TRICHOMONAS RAPID TESTS, THROUGH 2010 (MILLIONS)
  • Table 43 RELATIVE MARKET SHARE CHLAMYDIA/TRICHOMONAS RAPID TEST MANUFACTURERS (%)
  • Table 44 SELECTED LISTING CLIA APPROVED CHLAMYDIA/TRICHOMONAS RAPID TESTS
    • Hematology and Hemostasis
      • Hemostasis (Coagulation)
  • Table 45 FORECAST FOR THE U.S. HEMOGLOBIN/HEMOSTASIS RAPID TEST, THROUGH 2010 (MILLIONS)
  • Table 46 RELATIVE MARKET SHARE HEMATOLOGY/HEMOSTASIS POC RAPID TEST MANUFACTURERS (%)
  • Table 47 SELECTED LISTING CLIA APPROVED HEMATOLOGY/HEMOSTASIS RAPID TESTS
  • Table 47 (CONTINUED)
    • Urinalysis
  • Table 48 FORECAST FOR THE U.S. URINALYSIS RAPID TESTS, THROUGH 2010 (MILLIONS)
    • Market Size and Participants
  • Table49 RELATIVE MARKET SHARE OF POC URINE TEST MANUFACTURERS (%)
  • Table 50 SELECTED TESTING CLIA APPROVED URINALYSIS RAPID TESTS
  • Table 50 (CONTINUED)
    • HIV TESTING
      • OraSure
      • Trinity Botech plc
  • Table 51 FORECAST FOR THE U.S. RAPID POC HIV TESTING MARKET, THROUGH 2010 ($ MILLION)
  • Table 52 POC HIV COMPANIES RELATIVE MARKET SHARE (%)
    • Professional and Home Use Rapid Tests
      • Pregnancy/Fertility
  • Table 53 PREGNANCY/FERTILITY RAPID TESTS, THROUGH 2010 (MILLIONS)
  • Figure 10 PREGNANCY/FERTILITY RAPID TESTS, 2005 AND 2010 ($ MILLIONS)
  • Table 54 RELATIVE MARKET SHARE OF PREGNANCY TEST MANUFACTURERS (%)
  • Table 55 RECENT (2005) CLIA APPROVED PREGNANCY RAPID TESTS
  • Table 55 (CONTINUED)
    • Drug Testing
      • Market Size and Participants
  • Table 56 FORECAST FOR THE U.S. DRUG RAPID TESTS, THROUGH 2010 (MILLIONS)
  • Table 57 RELATIVE MARKET SIZE DRUG SCREENING RAPID TEST MANUFACTURERS (%)
  • Table 58 SELECTED LISTING CLIA APPROVED DRUG SCREENING RAPID TESTS
    • Fecal and Gastric Occult Blood
  • Table 59 FORECAST FOR THE U.S. FECAL AND GASTRIC OCCULT BLOOD RAPID TESTS, THROUGH 2010 (MILLIONS)
    • Market Share and Participants
  • Table 60 RELATIVE MARKET SHARE POC OCCULT BLOOD TESTING MANUFACTURERS (%)
  • Table 61 CLIA APPROVED FECAL AND GASTRIC OCCULT BLOOD RAPID TESTS
  • Table 61 (CONTINUED)
    • Cholesterol
      • Market Size and Participants
  • Table 62 FORECAST FOR THE U.S. CHOLESTEROL RAPID TESTS, THROUGH 2010 (MILLIONS)
  • Table 63 RELATIVE MARKET SHARE OF CHOLESTEROL POC RAPID TEST MANUFACTURERS (%)
  • Table 64 SELECTED LISTING CLIA APPROVED CHOLESTEROL RAPID TESTS
    • CONNECTIVITY - DATA MANAGEMENT
      • Connectivity Industry Consortium (CIC)
        • Requirements for Integrating POC Data to HIS/LIS
  • Figure 11 SCHEMATIC POC AND HIS/LIS CONNECTIVITY SYSTEM
    • Issues Relating to Implementing POC Connectivity
    • Currently Market POC Vendor Data Management Systems
  • Table 65 SELECTED LISTING OF POC DEVICE LINKED DATA MANAGEMENT PRODUCTS
    • MediSense Precision Net
    • Rapidlink
    • Impact
    • DataLink
    • Radiance Data Management System (DMS)
    • Nova Patient Management System
    • Diametrics IDMS-IRMA Data Management System
    • Cobas IT 1000 solution
    • Wireless Communication
    • Cost Analysis POC Testing Connectivity System
  • Table 66 THEORETICAL COMPONENT COST ANALYSIS ($)
    • Potential Market Size
    • Market Participants POC Data Management Systems
      • Misys Healthcare Systems
      • Data Innovations
      • SCC Soft Computer
      • LabSoft Inc.
      • Schuyler House
      • ClinLab Inc.
      • ClinLab Inc.
• TECHNOLOGY
  • BIOSENSORS
    • WHAT ARE BIOSENSORS?
      • Catalytic Sensors
      • Affinity Sensors
    • AMPEROMETRIC MEASUREMENT
    • COULOMETRY
  • ELECTRODES
    • WHAT ARE ELECTRODES?
  • IMMUNOASSAY ANALYTICAL METHODS
    • ENZYME IMMUNOASSAY (EIA)/RAPID ENZYME IMMUNOASSAY
    • LATEX AGGLUTINATION INHIBITION IMMUNOASSAY
    • MONOCLONAL ANTIBODIES
• PATENTS
  • NUMBER OF RECENTLY ISSUED PATENTS
  • Table 67 RESULTS OF PATENT SEARCH FOR POC CATEGORIES, SEPTEMBER 2004 - NOVEMBER 2005
    • ANALYSIS OF PATENT BY SUBJECT
  • Table 68 PATENTS BY SUBJECT AREA
    • PATENT ASSIGNEES
  • Table 69 LISTING OF PATENT ASSIGNESS
  • Table 69 (CONTINUED)
• WORLDWIDE POINT OF CARE MARKET
  • MARKET SIZE
  • Table 70 GLOBAL FORECAST FOR THE POC MARKET, THROUGH 2010 ($ BILLIONS)
    • GLOBAL MARKET SHARES
  • Table 71 POC GLOBAL MARKET SHARE BY COUNTRY (%)
    • PRESENCE OF U.S. MANUFACTURERS IN THE WORLDWIDE MARKET
      • Presence of U.S. Manufacturers�EContinued)
• PROFILES OF MAJOR MARKET PARTICIPANTS
  • MARKET PARTICIPANTS
  • ABBOTT LABORATORIES
  • BAYER CORPORATION.
  • BECKMAN COULTER INC.
  • BIOSITE INCORPORATED
  • DADE BEHRING, INC.
  • HYPOGUARD USA
  • INSTRUMENTATION LABORATORIES (IL)
  • INTERNATIONAL TECHNIDYNE CORP.
  • INVERNESS MEDICAL INNOVATONS
  • JOHNSON AND JOHNSON
  • NOVA BIOMEDICAL
  • QUIDEL CORPORATION
  • RESPONSE BIOMEDICAL
  • ROCHE DIAGNOSTICS
• APPENDIX
  • RECENTLY ISSUED PATENTS
    • BLOOD GAS TESTING
    • RAPID TESTING KITS
    • NEAR PATIENT TESTING
    • POC TESTING
    • GLUCOSE METERS
      • Glucose Meters (Continued)
      • Glucose Meters (Continued)
      • Glucose Meters (Continued)
      • Glucose Meters (Continued)
    • HEMATOLOGY
      • Hematology (Continued)
      • Hematology (Continued)
      • Hematology (Continued)
    • COAGULATION
    • IMMUNOASSAY KITS
      • Immunoassay Kits (Continued)
      • Immunoassay Kits (Continued)
      • Immunoassay Kits (Continued)
      • Immunoassay Kits (Continued)
• LIST OF TABLES
• Summary Table:
• Table 1 SELECTED KEY STATISTICS POC TESTING SITES
• Table 2 SELECTED POC TESTS - CLIA WAIVED
• Table 3 PERTINENT PARAMETERS OF GMP REGULATIONS AFFECTING IN VITRO DIAGNOSTICS
• Table 4 U.S. POPULATION PROJECTIONS OF THOSE AGED 55+, 2000 AND 2010 (MILLIONS)
• Table 5 FORECAST FOR THE U.S. POC MARKET BY VOLUME AND VALUE, THROUGH 2010 (MILLIONS)
• Table 6 MARKET SHARE POC MARKET PARTICIPANTS (%)
• Table 7 FORECAST FOR THE U.S. GLUCOSE METERS AND RELATED SUPPLIES MARKET, THROUGH 2010 (MILLIONS)
• Table 8 HOME USE GLUCOSE METER SALES BY TYPE OF DIABETES, THROUGH 2010 (MILLIONS)
• Table 9 FORECAST OF U.S. GLUCOSE METER RELATED SALES, THROUGH 2010 (MILLIONS)
• Table 10 RECENTLY APPROVED CLIA POC BLOOD GLUCOSE METERS,* 2005
• Table 11 RELATIVE MARKET SHARE GLUCOSE METERS AND SUPPLIES, 2005 (%)
• Table 12 BAYER GLUCOSE METER PRICES
• Table 13 ABBOTT GLUCOSE METER PRICES
• Table 14 LIFESCAN (J&J) GLUCOSE METER PRICES
• Table 15 ROCHE GLUCOSE METER PRICES
• Table 16 SELECTED LISTING OF RETAILERS SELLING HOME DIAGNOSTICS METERS UNDER THEIR NAME
• Table 17 HOME DIAGNOSTICS GLUCOSE METER PRICES
• Table 18 HYPOGUARD USA GLUCOSE METER PRICES
• Table 19 SELECTED LISTING OF BLOOD GLUCOSE MONITORS CAPABLE OF INTERACTING WITH COMPUTER SOFTWARE
• Table 20 FORECAST OF THE U.S. BLOOD GAS/ELECTROLYTE TESTING MARKET, THROUGH 2010 (MILLIONS)
• Table 21 RELATIVE MARKET SHARE BLOOD GAS ANALYZER MANUFACTURERS (%)
• Table 22 CLIA APPROVED POC BLOOD GAS ANALYZERS
• Table 23 NOVA BIOCHEMICAL POC STAT PROFILE PHOX SERIES BY AVAILABLE TESTS
• Table 24 FORECAST FOR THE U.S. CARDIAC MARKER TESTING MARKET, THROUGH 2010
• Table 25 CARDIAC MARKET TESTS BY COMPANY
• Table 26 RELATIVE SHARE POC CARDIAC MARKER MANUFACTURERS (%)
• Table 27 FORECAST FOR THE U.S. POC RAPID TEST MARKET, THROUGH 2010 (MILLIONS)
• Table 28 FORECAST FOR THE U.S. STREP A RAPID TEST, THROUGH 2010 (MILLIONS)
• Table 29 MARKET SHARE STREP A RAPID TEST MANUFACTURERS (%)
• Table 30 SELECTED LISTING CLIA APPROVED STREP A RAPID TESTS
• Table 31 FORECAST FOR THE U.S. H. PYLORI RAPID TESTS, -THROUGH 2010 (MILLIONS)
• Table 32 RELATIVE MARKET SHARE H. PYLORI POC RAPID TEST MANUFACTURERS (%)
• Table 33 SELECTED LIST CLIA APPROVED H. PYLORI RAPID TESTS
• Table 34 FORECAST FOR THE U.S. RSV RAPID TESTS, THROUGH 2010 (MILLIONS)
• Table 35 SELECTED LISTING CLIA APPROVED RSV TESTS
• Table 36 FORECAST FOR THE U.S. INFLUENZA RAPID TESTS, THROUGH 2010 (MILLIONS)
• Table 37 RELATIVE MARKET SHARE INFLUENZA POC RAPID TEST MANUFACTURERS (%)
• Table 38 SELECTED LISTING CLIA APPROVED INFLUENZA RAPID TESTS
• Table 39 FORECAST FOR THE U.S. INFECTIOUS MONONUCLEOS RAPID TESTS, -THROUGH 2010 (MILLIONS)
• Table 40 MARKET SHARE POC INFECTIOUS MONONUCLEOSIS RAPID TESTS (%)
• Table 41 SELECTED INTEREST CLIA APPROVED INFECTIOUS MONONUCLEOSIS RAPID TESTS
• Table 42 FORECAST FOR THE U.S. CHLAMYDIA/TRICHOMONAS RAPID TESTS, THROUGH 2010 (MILLIONS)
• Table 43 RELATIVE MARKET SHARE CHLAMYDIA/TRICHOMONAS RAPID TEST MANUFACTURERS (%)
• Table 44 SELECTED LISTING CLIA APPROVED CHLAMYDIA/TRICHOMONAS RAPID TESTS
• Table 45 FORECAST FOR THE U.S. HEMOGLOBIN/HEMOSTASIS RAPID TEST, THROUGH 2010 (MILLIONS)
• Table 46 RELATIVE MARKET SHARE HEMATOLOGY/HEMOSTASIS POC RAPID TEST MANUFACTURERS (%)
• Table 47 SELECTED LISTING CLIA APPROVED HEMATOLOGY/HEMOSTASIS RAPID TESTS
• Table 48 FORECAST FOR THE U.S. URINALYSIS RAPID TESTS, THROUGH 2010 (MILLIONS)
• Table49 RELATIVE MARKET SHARE POC URINE TEST MANUFACTURERS (%)
• Table 50 SELECTED TESTING CLIA APPROVED URINALYSIS RAPID TESTS
• Table 51 FORECAST FOR THE U.S. RAPID POC HIV TESTING MARKET, THROUGH 2010 ($ MILLION)
• Table 52 POC HIV COMPANYS RELATIVE MARKET SHARE (%)
• Table 53 PREGNANCY/FERTILITY RAPID TESTS, THROUGH 2010 (MILLIONS)
• Table 54 RELATIVE MARKET SHARE PREGNANCY TEST MANUFACTURERS (%)
• Table 55 RECENT (2005) CLIA APPROVED PREGNANCY RAPID TESTS
• Table 56 FORECAST FOR THE U.S. DRUG RAPID TESTS, THROUGH 2010 (MILLIONS)
• Table 57 RELATIVE MARKET SIZE DRUG SCREENING RAPID TEST MANUFACTURERS (%)
• Table 58 SELECTED LISTING CLIA APPROVED DRUG SCREENING RAPID TESTS
• Table 59 FORECAST FOR THE U.S. FECAL AND GASTRIC OCCULT BLOOD RAPID TESTS, THROUGH 2010 (MILLIONS)
• Table 60 RELATIVE MARKET SHARE POC OCCULT BLOOD TESTING MANUFACTURERS (%)
• Table 61 CLIA APPROVED FECAL AND GASTRIC OCCULT BLOOD RAPID TESTS
• Table 62 FORECAST FOR THE U.S. CHOLESTEROL RAPID TESTS, THROUGH 2010 (MILLIONS)
• Table 63 RELATIVE MARKET SHARE CHOLESTEROL POC RAPID TEST MANUFACTURERS (%)
• Table 64 SELECTED LISTING CLIA APPROVED CHOLESTEROL RAPID TESTS
• Table 65 SELECTED LISTING OF POC DEVICE LINKED DATA MANAGEMENT PRODUCTS
• Table 66 THEORETICAL COMPONENT COST ANALYSIS ($)
• Table 67 RESULTS OF PATENT SEARCH FOR POC CATEGORIES, SEPTEMBER 2004 - NOVEMBER 2005
• Table 68 PATENTS BY SUBJECT AREA
• Table 69 LISTING OF PATENT ASSIGNESS
• Table 70 GLOBAL FORECAST FOR THE POC MARKET, THROUGH 2010 ($ BILLIONS)
• Table 71 GLOBAL MARKET SHARE BY COUNTRY POC MARKET (%)
• LIST OF FIGURES
• Summary Figure:
• Figure 1 U.S. POPULATION PROJECTIONS OF THOSE AGED 55+, 2000 AND 2010 (MILLIONS)
• Figure 2 FORECAST VALUE FOR THE U.S. POC MARKET, 2005 AND 2010 ($ MILLIONS)
• Figure 3 MARKET SHARE POC MARKET PARTICIPANTS (%)
• Figure 4 DISTRIBUTION CHANNELS: POC DIAGNOSTIC DEVICES
• Figure 5 FORECAST FOR THE U.S. GLUCOSE METERS AND RELATED SUPPLIES MARKET, 2005 AND 2010 ($ MILLIONS)
• Figure 6 HOME USE GLUCOSE METER SALES BY TYPE OF DIABETES, 2005 AND 2010 ($ MILLIONS)
• Figure 7 RELATIVE MARKET SHARE GLUCOSE METERS AND SUPPLIES, 2005 (%)
• Figure 8 RELATIVE MARKET SHARE BLOOD GAS ANALYZER MANUFACTURERS (%)
• Figure 9 FORECAST FOR THE U.S. POC RAPID TEST MARKET, 2005 AND 2010 ($ MILLIONS)
• Figure 10 PREGNANCY/FERTILITY RAPID TESTS, 2005 AND 2010 ($ MILLIONS)
• Figure 11 SCHEMATIC POC AND HIS/LIS CONNECTIVITY SYSTEM